45.70
price down icon0.13%   -0.06
after-market Dopo l'orario di chiusura: 46.15 0.45 +0.98%
loading

Halozyme Therapeutics Inc Azioni (HALO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
14.85%
195.88
230.04 216.03 221.04 162.14
Cost Of Revenue
45.83%
28.33
52.30 54.82 50.07 35.17
Gross Profit
5.73%
167.55
177.74 161.21 170.97 126.97
Operating Expenses
6.12%
72.01
76.71 72.93 76.51 73.17
Interest Income/Expense
13.66%
4.507
5.22 4.505 4.494 4.543
Benefits Costs and Expenses
22.51%
99.85
128.86 114.27 127.88 109.91
Costs And Expenses
22.22%
100.34
129.00 127.75 126.58 108.34
Operating Income/Loss
5.44%
95.54
101.03 88.28 94.46 53.80
Income/Loss From Continuing Operations Before Tax
5.09%
96.03
101.17 101.76 93.16 52.24
Income Tax Expense/Benefit
21.65%
19.20
15.79 19.92 18.40 12.62
Income/Loss From Continuing Operations After Tax
10.03%
76.82
85.39 81.84 74.75 39.62
Net Income/Loss
10.03%
76.82
85.39 81.84 74.75 39.62
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
13,200%
126.94
-0.969 131.97 131.73 135.03
Diluted Average Shares
12,541%
128.89
-1.036 134.08 133.54 137.90
Basic Earnings Per Share
6.15%
0.61
0.65 0.62 0.57 0.29
Diluted Earnings Per Share
7.69%
0.60
0.65 0.61 0.56 0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):